fda status of bpc 157 and tb 500 BPC-157, TB-500, KPV, GHK-Cu 80mg (Klow Blend) Side Effects fda warning bpc-157 unapproved peptide
Description
BPC-157 remains investigational rather than proven therapy, so safety and effectiveness require stronger human clinical evidence before routine medical use
economic policy
Service availability varies by state, and we do not currently operate in Kansas, Louisiana, Mississippi, or New Mexico
May-Jun 2013;23(3):143-7
